85
53
Growth Score
-2 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1072824
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.
Acquired by 
Bristol-Myers Squibb
Micheal Step: Vice President, Corporate DevelopmentPast Role: Santarus, Senior Vice President of Corporate Development
About the Company
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs.
Develops a line of diagnostic and therapeutic products for diabetics.
Working towards a cure for diabetes by challenging science, changing lives. Amylin employees are dedicated in their ability to "think outside the
box". Because of our commitment of constantly finding newer and better ways to treat diabetes, we come to work each day feeling like we CAN make a difference in our world.
